{"cdcTestId":"2013-0303","testcaseName":"Dose 2 to 3, interval 4 weeks","vaccineGroup":"HIB","evaluationTestType":"Interval: At Minimum","forecastTestType":"Recommended based on age","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2022-05-21T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-07-21T00:00:00","vaccineName":"ACTHIB","cvx":"48","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-09-21T00:00:00","vaccineName":"ACTHIB","cvx":"48","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"ACTHIB","cvx":"48","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"4","earliestDate":"2023-05-21T00:00:00","recommendedDate":"2023-05-21T00:00:00","pastDueDate":"2023-10-18T00:00:00"},"doses":[{"dateAdministered":"2022-07-21T00:00:00","vaccineName":"ACTHIB","cvx":"48","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-09-21T00:00:00","vaccineName":"ACTHIB","cvx":"48","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"ACTHIB","cvx":"48","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-05-22T12:41:16.336","generalDescription":"This test case describes when a child is administered the third dose of the Hib vaccine at an interval of 4 weeks after the second dose that the dose is valid.  Another dose should be forecast.","changedInVersion":"1.0","reasonForChange":""}